I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Retinitis Pigmentosa: Understanding Inherited Vision Loss
What Is Retinitis Pigmentosa?
RP is a group of inherited diseases that cause the light-sensing cells of the retina to break down gradually over time. It is considered the most common inherited retinal disease and a leading cause of vision loss in adults under 60. Roughly 100,000 Americans and an estimated 1.5 million people worldwide are living with this condition.
The retina contains two types of photoreceptors, which are the specialized cells that detect light and send signals to the brain. Rod cells manage night vision and peripheral, or side, vision. Cone cells are responsible for central vision, sharp detail, and color perception. In most forms of RP, rod cells begin to fail first. This explains why night blindness and shrinking side vision are usually the earliest signs of the disease.
As the condition progresses, cone cells are affected as well. When this happens, central vision, color perception, and the ability to see fine detail all begin to decline. The rate at which this occurs varies greatly from person to person, even among family members who carry the same genetic mutation.
RP is caused by mutations in genes that produce proteins essential for keeping photoreceptor cells alive and functioning. When these proteins are defective, the cells gradually stop working and die. More than 100 different genes have been linked to RP, making it one of the most genetically complex inherited conditions in all of eye medicine. Within individual genes, dozens or even hundreds of distinct mutations can each produce the disease.
During a dilated eye examination, a retina specialist can often spot characteristic signs of RP directly. These include dark pigment deposits in the retina sometimes described as bone spicule pigmentation, narrowing of the blood vessels inside the retina, and a pale or waxy appearance of the optic nerve. When these findings appear together, they point the specialist toward an RP diagnosis and guide the next steps in testing.
Who Is at Risk?
Because RP is a genetic condition, the most significant risk factor is having a close family member who has already been diagnosed. Understanding the specific inheritance pattern in your family helps clarify the likelihood of RP in other relatives and in future generations.
RP follows several different patterns of inheritance, and knowing which applies to your family has real implications for risk assessment.
- Autosomal dominant RP requires only one copy of the mutated gene to cause the condition. A child of an affected parent has roughly a one-in-two chance of inheriting it, accounting for about 10 to 20 percent of all cases.
- Autosomal recessive RP requires both copies of the relevant gene to be mutated. Each parent typically carries one silent copy without symptoms, and each child then has about a one-in-four chance of being affected. This pattern accounts for roughly 20 percent of cases.
- X-linked RP primarily affects males and accounts for approximately 10 to 20 percent of cases. Females who carry the mutation may experience mild or no symptoms but can pass the mutation to their sons.
- Sporadic cases occur without any known family history and may result from a new mutation not inherited from either parent.
A genetic counselor, working alongside your retina specialist, can identify which inheritance pattern applies to your family and explain what that means for other relatives.
Having a parent, sibling, or close relative diagnosed with RP significantly increases the likelihood of carrying a related gene mutation. In families where parents share a close biological relationship, the risk for autosomal recessive forms of RP is higher because both parents are more likely to carry the same recessive mutation.
In some people, RP occurs as part of a condition that affects other body systems as well. Usher syndrome is the most common of these, combining RP-related vision loss with hearing loss that is present from birth or early childhood. Bardet-Biedl syndrome is another example, involving RP alongside features such as obesity and kidney problems. Genetic testing can help determine whether RP is occurring on its own or as part of a broader inherited syndrome.
Recognizing the Symptoms
RP symptoms typically develop gradually, often beginning in childhood or early adolescence. Because the changes happen slowly, many people adapt without fully recognizing how much their vision has shifted. Knowing the warning signs, especially in children, can lead to earlier diagnosis and better long-term planning.
Difficulty seeing in dim light or complete darkness is typically the earliest symptom of RP and is known medically as nyctalopia, or night blindness. A person with early RP may struggle to move around a darkened room, have difficulty driving at dusk, or take much longer than expected to adjust when stepping from a bright space into a dim one. These challenges are easy to dismiss at first, which is part of why RP often goes undiagnosed for years.
As rod cells continue to deteriorate, the outer edges of the visual field progressively shrink. People with RP may begin bumping into objects at the sides of their path, missing things that are not directly in front of them, or feeling disoriented in crowded or busy spaces. Over time, this narrowing can develop into what is often described as tunnel vision, where only a limited central area of sight remains.
In later stages of RP, the cone cells that support central vision also begin to fail. Reading, recognizing faces, and performing tasks that require sharp detail all become progressively harder, and color perception may also change. The timing of central vision loss varies considerably between individuals. Some people retain useful central sight well into adulthood, while others experience earlier decline.
Children often cannot describe vision problems clearly, or they may not realize that what they experience is unusual for others. Parents should pay attention to signs such as tripping or bumping into furniture in low light, hesitation or anxiety in dim environments, reluctance to go outside after dark, and difficulty keeping up with peers in activities that rely on peripheral awareness. If any of these patterns emerge, a prompt evaluation by a retina specialist is strongly recommended.
How RP Is Diagnosed
Diagnosing RP involves much more than a routine vision check. A comprehensive evaluation by a retina specialist combines a detailed exam of the retina, specialized electrical testing, high-resolution imaging, and increasingly, genetic analysis. Together, these tools confirm the diagnosis, identify the underlying mutation, and establish a baseline for monitoring vision over time.
During a dilated eye exam, drops are placed in the eye to widen the pupil, allowing the retina specialist to examine the back of the eye in full detail. The combination of bone spicule pigment deposits, narrowed retinal blood vessels, and a pale optic disc often provides the first direct evidence of RP. This exam is the foundation of the diagnostic process and is typically where the evaluation begins.
Electroretinography, commonly called ERG, is one of the most important tests for confirming RP. ERG measures the electrical signals produced by rod and cone cells in response to flashes of light. In people with RP, these signals are reduced or may not be detectable at all. Importantly, ERG can identify retinal dysfunction even before vision symptoms become noticeable, making it a valuable screening tool for family members who may carry a mutation but have not yet developed any symptoms.
Visual field testing maps the areas of vision that are still functioning and helps the specialist track how much peripheral vision remains over time. Optical coherence tomography (OCT) is a non-invasive imaging scan that produces detailed cross-sectional views of the retinal layers. OCT can reveal thinning of the retina and other structural changes associated with RP, giving the specialist a precise picture of how the disease is affecting the eye at a structural level and how it may be changing between visits.
Genetic testing has become a central part of diagnosing and managing RP. A blood or saliva sample is analyzed to identify the specific gene mutation responsible for the condition. This information confirms the diagnosis, clarifies the inheritance pattern, supports family planning decisions, and determines whether a patient may qualify for gene therapy or enrollment in a clinical trial. As new targeted treatments continue to emerge, knowing the exact genetic cause is more important than ever.
Treatment and Management
There is currently no treatment that can fully reverse the vision loss caused by RP. However, meaningful options exist to slow progression in specific cases, manage related complications, and support quality of life. Research in this field is advancing more rapidly than at any previous point, and new therapies are working their way through clinical development.
The most significant treatment advance in inherited retinal disease in recent history is an FDA-approved gene therapy targeting a mutation in the RPE65 gene. This therapy delivers a functional copy of the RPE65 gene directly into retinal cells through a surgical procedure performed by a vitreoretinal surgeon. It is designed for patients whose RP or related condition called Leber congenital amaurosis is caused specifically by mutations in both copies of the RPE65 gene. Clinical studies showed meaningful improvements in the ability to navigate in low-light conditions following treatment.
This therapy applies to only a small fraction of people with RP, since RPE65 mutations represent one of more than 100 gene variants that can cause the condition. Genetic testing is required to determine whether this treatment is an option for any individual patient.
RP can give rise to secondary eye conditions that add to vision loss beyond the core disease. Two of the most common are cataracts and cystoid macular edema.
- Cataracts involve clouding of the eye's natural lens and are more prevalent in people with RP. Cataract surgery can remove the cloudy lens and often improves functional vision meaningfully.
- Cystoid macular edema is swelling in the central retina that some RP patients develop. It can sometimes be managed with medication, and treating it may help preserve the central vision that remains.
Identifying and addressing these complications in a timely way is an important part of comprehensive RP management.
Some research has explored whether vitamin A palmitate might slow the rate of retinal degeneration in certain forms of RP. However, vitamin A at high doses can cause liver damage and is not safe for everyone. Pregnant women and those planning to become pregnant should not take high-dose vitamin A. Any nutritional supplementation related to RP should only be undertaken under direct guidance from a retina specialist.
Low vision rehabilitation helps people with RP use their remaining sight as effectively as possible. Specialists in this field can recommend tools and training tailored to each person's level of functional vision.
- Magnifying lenses and telescopic glasses for reading and close work
- High-contrast screen settings and large-print materials
- Text-to-speech software and screen reading technology
- Orientation and mobility training for safe, confident movement through various environments
Our team can provide referrals to low vision services as part of ongoing care for patients managing RP.
Living with RP and Planning for the Future
RP is a progressive condition, meaning that vision tends to change gradually over a person's lifetime. Understanding what to expect and taking thoughtful steps to prepare can make a meaningful difference in day-to-day life and long-term well-being.
The pace of RP differs considerably from person to person, even among family members who share the same gene mutation. Some individuals maintain useful functional vision for many decades, while others experience a faster course of decline. X-linked forms of RP tend to progress more rapidly, particularly in males. The specific gene involved, the type of inheritance, and individual biological factors all influence how the disease unfolds over time.
While no approach has been proven to stop RP entirely, certain habits are broadly recommended to reduce additional stress on the retina. Wearing UV-blocking sunglasses outdoors may help shield the retina from light-related damage. Avoiding smoking is strongly encouraged, as it has been associated with worse outcomes in multiple retinal conditions. Maintaining overall physical health through regular exercise and a balanced diet also supports retinal health more broadly.
Research into RP is progressing on several fronts. Gene therapies targeting mutations beyond RPE65, including those responsible for X-linked RP, are in advanced stages of clinical testing. Optogenetic therapy, which aims to restore light sensitivity in surviving retinal cells even after photoreceptors are lost, has shown early promise in clinical studies. Gene-editing approaches are also being explored in laboratory settings, though they remain investigational at this stage.
These therapies are not yet broadly available outside of clinical trials for most mutations. A retina specialist can help determine whether you may qualify for a trial and will keep you informed as new therapies move closer to approval.
Living with RP involves more than managing vision. A progressive diagnosis can bring grief, anxiety, and genuine uncertainty about the future, and these responses are completely understandable. Support groups, mental health counseling, and organizations dedicated to inherited retinal diseases can provide both practical guidance and meaningful connection with others navigating similar experiences. Addressing the emotional dimension of RP is as important as managing the medical side.
Because RP changes over time, learning adaptive skills while vision is still relatively functional tends to make later transitions smoother. This might include practicing with assistive technology before it is urgently needed, discussing driving alternatives with family and care providers, and making safety-oriented adjustments to the home environment. Ongoing visits with your retina specialist ensure that your care plan reflects where your vision is today and anticipates where it may be heading.
When to See a Retina Specialist
Consistent ongoing care from a retina specialist is essential for anyone living with RP. Beyond routine monitoring, certain symptoms require same-day attention, as some complications associated with the condition need urgent treatment to prevent serious harm.
Although RP itself progresses slowly, some symptoms signal a problem that cannot wait. A sudden increase in floaters (small moving shapes or spots drifting through vision), flashes of light in one or both eyes, a shadow or dark curtain spreading across any part of your visual field, or a rapid unexplained loss of vision should all be treated as an emergency. These symptoms may indicate a retinal detachment or another serious complication requiring immediate treatment. If you experience any of these, contact a retina specialist right away or go to the nearest emergency room without delay.
Even when vision feels stable, regular appointments allow your retina specialist to track changes in retinal structure and function before they become more significant. ERG, visual field testing, and OCT imaging form the core of ongoing RP monitoring and help detect complications such as cataracts or macular edema early, when they are most treatable. These visits also ensure that newly available therapies relevant to your specific mutation are considered as soon as they become an option.
If RP is suspected based on your symptoms or family history, speaking with a retina specialist about genetic testing is a meaningful first step. Knowing the specific mutation involved lays the groundwork for targeted care and becomes increasingly valuable as gene-directed therapies and clinical trials continue to expand. Even if no treatment currently targets your specific mutation, having the genetic profile documented means you can be matched with emerging options as they develop.
Frequently Asked Questions
Below are answers to questions we hear most often from patients and families navigating an RP diagnosis. If your situation is not addressed here, our team is happy to help you find the guidance you need.
In many cases, yes. ERG can identify reduced electrical activity in the retina before any noticeable vision changes occur, and genetic testing can detect a disease-causing mutation in a family member who currently has normal vision. If RP runs in your family, proactive testing is a conversation worth having with your retina specialist even if you feel your vision is entirely fine. Establishing a baseline before symptoms develop opens the door to earlier monitoring and potential clinical trial participation if the disease begins to progress.
Not yet. The only currently FDA-approved gene therapy for an inherited retinal disease targets the RPE65 gene mutation specifically, which is responsible for only a small fraction of all RP cases. Gene therapies aimed at other mutations are actively being studied in clinical trials and have shown promising early results, but most have not yet received regulatory approval. Genetic testing is the essential first step in determining whether any existing or developing therapy applies to your particular form of the disease.
The answer depends on the inheritance pattern and the specific mutation identified in your family. In autosomal dominant RP, each child of an affected parent has roughly a one-in-two chance of inheriting the condition. In autosomal recessive RP, each child faces about a one-in-four chance when both parents carry the mutation. In X-linked RP, a carrier mother has roughly a one-in-two chance of passing the mutation to each son. A genetic counselor working alongside your retina specialist can provide risk estimates specific to your family's results and help you think through the implications for family planning.
No lifestyle change has been proven to stop RP from progressing. That said, protecting your eyes from ultraviolet light with quality sunglasses, avoiding smoking, and supporting general health through a nutritious diet and regular physical activity are broadly recommended. If your specialist discusses vitamin A supplementation, it is important to understand that high doses carry real risks, particularly to the liver, and this should never be started without direct medical supervision and ongoing monitoring.
A comprehensive evaluation with a retina specialist is still worthwhile, even without any current vision complaints. ERG and a dilated examination can establish a baseline and may detect early retinal changes that are not yet apparent to you. If you are thinking about starting a family, this is also a valuable time to meet with a genetic counselor to understand what the implications might be for your children. Having this information before symptoms develop puts you in the strongest position to respond effectively if the disease does begin to progress.
The appropriate monitoring schedule depends on your current level of vision, how quickly your condition appears to be changing, and whether any related complications such as macular edema are being managed. Most patients with RP benefit from at least one comprehensive visit per year, with more frequent appointments if active changes are detected. Your retina specialist will recommend a schedule based on your individual situation and will adjust it over time as your needs evolve.
Specialized Retina Care Throughout Connecticut
New England Retina Associates has been dedicated exclusively to retinal care since 1995, and our fellowship-trained vitreoretinal surgeons have deep experience diagnosing and managing inherited retinal diseases including retinitis pigmentosa. We offer access to advanced diagnostic testing, current treatment options, and guidance on emerging therapies and clinical research opportunities across all four of our Connecticut office locations. If you or a family member has received an RP diagnosis or has concerns about inherited vision loss, we warmly encourage you to schedule an appointment with our team.
30 Years of Care & Commitment
